Aspirin resistance in patients with chronic renal failure.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  JN. Journal of Nephrology (Milano. 1992)

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5301/JN.2011.6259PMID 21279952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis.

  2008cited by this paper
• Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.

  2008cited by this paper
• Aspirin “Resistance”

  2008cited by this paper
• Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients.

  2008cited by this paper
• Platelet inhibition by aspirin 81 and 325 mg/day in men versus women without clinically apparent cardiovascular disease.

  2008cited by this paper
• The role of aspirin in cardiovascular prevention: implications of aspirin resistance.

  2008cited by this paper
• Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome.

  2008cited by this paper
• Resistenz gegenüber Plättchenfunktionshemmern: ein reales klinisches Problem

  2008cited by this paper
• Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis

  2008cited by this paper
• The frequency of aspirin resistance and its risk factors in patients with metabolic syndrome.

  2007cited by this paper
• Cardiology: Aspirin Resistance in Patients with Stable Coronary Artery Disease with and without a History of Myocardial Infarction

  2007cited by this paper
• Variable Platelet Response to Aspirin in Patients with Ischemic Stroke

  2007cited by this paper
• Aspirin resistance: what, why and when?

  2007cited by this paper
• Aspirin resistance in secondary stroke prevention

  2006cited by this paper
• Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA1/2 polymorphism

  2006cited by this paper
• Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?

  2006cited by this paper
• Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance.

  2006cited by this paper
• Aspirin resistance.

  2006cited by this paper
• Acute renal failure in intensive care unit: which factors predict future dialysis dependency?

  2006cited by this paper
• Prevalence of aspirin resistance in patients with type 2 diabetes

  2005cited by this paper
• Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism

  2005cited by this paper
• Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.

  2005cited by this paper
• Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction.

  2005cited by this paper
• Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.

  2005cited by this paper
• The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.

  2005cited by this paper
• Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels

  2005cited by this paper
• Glycoprotein IIIA Gene (PIA) Polymorphism and Aspirin Resistance: Is There Any Correlation?

  2005cited by this paper
• Cyclooxygenase‐1 haplotype modulates platelet response to aspirin

  2005cited by this paper
• Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects.

  2005cited by this paper
• Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

  2005cited by this paper
• Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

  2004cited by this paper
• Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.

  2004cited by this paper
• Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?

  2004cited by this paper
• Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control.

  2004cited by this paper
• Aspirin resistance

  2004cited by this paper
• Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery

  2003cited by this paper
• Aspirin resistance: definition, mechanisms and clinical read‐outs

  2003cited by this paper
• Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms.

  2003cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin.

  2002cited by this paper
• Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets.

  2002cited by this paper
• Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

  2001cited by this paper
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

  2001cited by this paper
• Defective platelet response to arachidonic acid and thromboxane A2 in subjects with PlA2 polymorphism of β3 subunit (glycoprotein IIIa)

  2000cited by this paper
• Clinical epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper
• Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.

  1993cited by this paper
• Glomerular filtration rate measurements in clinical trials

  1993cited by this paper
• The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study.

  1991cited by this paper
• Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

  1988cited by this paper

• Impact of hemodialysis on efficacies of the antiplatelet agents in coronary artery disease patients complicated with end-stage renal disease

  2024cites this paper
• Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease

  2022cites this paper
• Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention

  2021cites this paper
• N-Terminal Pro-Brain Natriuretic Peptide and Right Ventricular Diameter Are Related to Aspirin Resistance in Coronary Artery Disease Patients

  2021cites this paper
• Evaluating Effectiveness and Safety in Chronic Kidney Disease with Atrial Flutter Using an Anticoagulation Strategy

  2020cites this paper
• Platelet aggregometry testing during aspirin or clopidogrel treatment and measurement of clopidogrel metabolite concentrations in dogs with protein‐losing nephropathy

  2020cites this paper
• Choice of Stents and Clinical Outcomes in Patients with Chronic Kidney Disease

  2020cites this paper
• Prevalence of high on-treatment platelet reactivity in patients with chronic kidney disease treated with acetylsalicylic acid for stroke prevention.

  2018cites this paper
• Global Trends in Aspirin Resistance‐Related Research from 1990 to 2015: A Bibliometric Analysis

  2017cites this paper
• Évaluation de l’intérêt de la transfusion plaquettaire dans les hématomes intracrâniens chez les patients traités par agents antiplaquettaires

  2017cites this paper
• Przewlekła choroba nerek a leczenie przeciwpłytkowe — co warto wiedzieć?

  2017cites this paper
• Low‐dose aspirin for prevention of cardiovascular disease in patients on hemodialysis: A 5‐y prospective cohort study

  2016cites this paper
• Risk of Cerebral Infarction in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study (MID study)

  2016cites this paper
• Establishing a predictive model for aspirin resistance in elderly Chinese patients with chronic cardiovascular disease

  2016cites this paper
• Antiplatelet effects of aspirin in chronic kidney disease patients

  2016cites this paper
• Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease.

  2016cites this paper
• INFLUENCE OF CHRONIC KIDNEY DISEASE ON THE HAEMOSTATIC PROPERTIES, THE PLATELET TRANSCRIPTOMIC AND PLASMA PROTEOMIC PROFILES OF CORONARY ARTERY DISEASE PATIENTS

  2016cites this paper
• Gestion du risque hémorragique et thrombotique en transplantation rénale

  2016cites this paper
• Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine

  2016cites this paper
• Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events

  2016cites this paper
• Antiplatelet resistance and the role of associated variables in stable patients treated with stenting

  2015cites this paper
• Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events

  2015cites this paper
• Aspirin Resistance in Patients Undergoing Hemodialysis and Effect of Hemodialysis on Aspirin Resistance

  2015influential citation
• Chronic aspirin and statin therapy in patients with impaired renal function and acute coronary syndromes: results from the IN-ACS Outcome Registry

  2014cites this paper
• High prevalence of aspirin resistance in elderly patients with cardiovascular disease (CVD) and hyperhomocysteinaemia.

  2014cites this paper
• Effectiveness and Safety of Antiplatelet in Stroke Patients with End-Stage Renal Disease Undergoing Dialysis

  2014cites this paper
• Aspirin resistance in patients with impaired renal functions.

  2014influential citation
• Kronik böbrek yetersizliği bulunan hastalarda antitrombosit ilaçlarin etkinliği ve emniyeti Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease

  2014cites this paper
• Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients?

  2014cites this paper
• [Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease].

  2014cites this paper
• Non-HDL cholesterol is an independent risk factor for aspirin resistance in obese patients with type 2 diabetes.

  2014cites this paper
• Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease

  2013cites this paper
• Haemodialysis impairs clopidogrel but not aspirin responsiveness in patients with end-stage renal disease

  2013cites this paper
• Atherosclerotic Coronary Artery Disease

  2013cites this paper
• ASPIRIN RESISTANCE IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT

  2013cites this paper
• Chronic lower limb ischemia and advanced renal failure. Do we possess sufficient therapeutic knowledge?

  2013cites this paper
• Renal function and aspirin resistance in patients with coronary artery disease.

  2012influential citation
• The Association between Dual Antiplatelet Responsiveness and the Level of Platelets in Acute Coronary Syndrome

  2012cites this paper
• High Platelet Reactivity and Antiplatelet Therapy Resistance

  2012cites this paper
• Contemporary Reviews in Cardiovascular Medicine Antithrombotic Therapy in Patients With Chronic Kidney Disease

  2012cites this paper
• Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.

  2012cites this paper
• Effect of chronic kidney disease on platelet reactivity to dual-antiplatelet therapy in patients treated with drug-eluting stents

  2012cites this paper
• Oral antiplatelet agents and chronic kidney disease.

  2011cites this paper
• Oral Antiplatelet Agents and Chronic Kidney

  2011cites this paper
• Accuracy and reliability of point-of-care platelet assays in hemodialysis patients

  2011cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper